Local immune dysregulation and subsequent inflammatory response contribute to pulmonary edema caused by Enterovirus infection in mice

Pulmonary edema that comes on suddenly is the leading cause of mortality in hand‐foot‐and‐mouth disease (HFMD) patients; however, its pathogenesis is still largely unclear. A range of research suggest immunopathogenesis during the occurrence of pulmonary edema in severe HFMD patients. Herein, to investigate the potential mechanism of immune dysregulation in the development of pulmonary edema upon Enterovirus (EV) infection, we established mouse infection models for Enteroviruses (EVs) including Coxsackievirus (CV) A6, Enterovirus A71 (EVA71), and CVA2 exhibiting a high incidence of pulmonary edema. We found that EVs infection induced an immune system disorder by reducing the numbers of pulmonary and circulatory T cells, B cells, macrophages, and monocytes and increasing the numbers of lung neutrophils, myeloid‐derived suppressor cells (MDSCs), and activated T cells. In addition, the concentrations of C−X−C motif chemokine ligand 1 (CXCL‐1), tumor necrosis factor‐alpha, monocyte chemoattractant protein‐1, and interleukin 6 were increased in EV‐infected lungs. Moreover, we found that EVs replication in mice lungs lead to apoptosis of lung cells and degradation of tight junction proteins. In conclusion, EVs infection likely triggered a complexed immune defense mechanism and caused dysregulation of innate immune cells (MDSCs, neutrophils, monocytes, and macrophages) and adaptive cellular immunity (B cells, T cells). This dysregulation increased the release of cytokines and other inflammatory factors from activated immune‐related cells and caused lung barrier damage and pulmonary edema.

[1]  V. Sánchez-Margalet,et al.  Myeloid-derived suppressor cells and vaccination against pathogens , 2022, Frontiers in Cellular and Infection Microbiology.

[2]  G. Duan,et al.  A mouse-adapted CVA6 strain exhibits neurotropism and triggers systemic manifestations in a novel murine model , 2022, Emerging microbes & infections.

[3]  P. Hu,et al.  Low-frequency, exhausted immune status of CD56dim NK cells and disordered inflammatory cytokine secretion of CD56bright NK cells associated with progression of severe HFMD, especially in EV71-infected patients. , 2021, International immunopharmacology.

[4]  J. Bailly,et al.  A large-scale outbreak of hand, foot and mouth disease, France, as at 28 September 2021 , 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[5]  C. Guatimosim,et al.  A Biosafety Level 2 Mouse Model for Studying Betacoronavirus-Induced Acute Lung Damage and Systemic Manifestations , 2021, Journal of virology.

[6]  G. Duan,et al.  The Disruption of the Endothelial Barrier Contributes to Acute Lung Injury Induced by Coxsackievirus A2 Infection in Mice , 2021, International journal of molecular sciences.

[7]  P. Horby,et al.  Seroprevalence and Virologic Surveillance of Enterovirus 71 and Coxsackievirus A6, United Kingdom, 2006–2017 , 2021, Emerging infectious diseases.

[8]  Linqing Zhao,et al.  Molecular epidemiology of coxsackievirus A16 circulating in children in Beijing, China from 2010 to 2019 , 2021, World Journal of Pediatrics.

[9]  U. Demkow,et al.  Neutrophil Extracellular Traps (NETs) in Severe SARS-CoV-2 Lung Disease , 2021, International journal of molecular sciences.

[10]  Dong Li,et al.  Pathological Features of Enterovirus 71-Associated Brain and Lung Damage in Mice Based on Quantitative Proteomic Analysis , 2021, Frontiers in Microbiology.

[11]  G. Duan,et al.  Neonatal Murine Model of Coxsackievirus A2 Infection for the Evaluation of Antiviral Therapeutics and Vaccination , 2021, Frontiers in Microbiology.

[12]  C. Launes,et al.  Surveillance for Enteroviruses Associated with Hand, Foot, and Mouth Disease, and Other Mucocutaneous Symptoms in Spain, 2006–2020 , 2021, Viruses.

[13]  Jing Ma,et al.  The epidemiological characteristics of enterovirus infection before and after the use of enterovirus 71 inactivated vaccine in Kunming, China , 2021, Emerging microbes & infections.

[14]  Jen-Ren Wang,et al.  Enterovirus A71: virulence, antigenicity, and genetic evolution over the years , 2019, Journal of Biomedical Science.

[15]  Linfu Zhou,et al.  Neutrophil extracellular traps induced by VP1 contribute to pulmonary edema during EV71 infection , 2019, Cell Death Discovery.

[16]  Yi Tan,et al.  Six amino acids of VP1 switch along with pandemic of CV-A6-associated HFMD in Guangxi, southern China, 2010-2017. , 2019, The Journal of infection.

[17]  M. Luo,et al.  Clinical features and phylogenetic analysis of severe hand-foot-and-mouth disease caused by Coxsackievirus A6. , 2019, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[18]  Hao Huang,et al.  Clinical and epidemiological characteristics of Coxsackievirus A6- and Enterovirus 71-associated clinical stage 2 and 3 severe Hand, Foot, and Mouth Disease in Guangxi, southern China, 2017. , 2019, The Journal of infection.

[19]  J. Chan,et al.  Enterovirus A71 Infection Activates Human Immune Responses and Induces Pathological Changes in Humanized Mice , 2018, Journal of Virology.

[20]  S. Jagtap.  Evaluation of CD4+ T-cells and CD8+ T-cells in triple-negative invasive breast cancer , 2018, Indian journal of pathology & microbiology.

[21]  B. Cowling,et al.  Emerging Enteroviruses Causing Hand, Foot and Mouth Disease, China, 2010–2016 , 2018, Emerging infectious diseases.

[22]  Chao Zhang,et al.  Mast cells contribute to Enterovirus 71 infection-induced pulmonary edema in neonatal mice , 2018, Laboratory Investigation.

[23]  S. Esposito,et al.  Hand, foot and mouth disease: current knowledge on clinical manifestations, epidemiology, aetiology and prevention , 2018, European Journal of Clinical Microbiology & Infectious Diseases.

[24]  S. Esposito,et al.  Hand, foot and mouth disease: current knowledge on clinical manifestations, epidemiology, aetiology and prevention , 2018, European Journal of Clinical Microbiology & Infectious Diseases.

[25]  D. Wei,et al.  Mortality in Children with Severe Hand, Foot and Mouth Disease in Guangxi, China , 2018, Indian Pediatrics.

[26]  Huifen Feng,et al.  Pulmonary edema following central nervous system lesions induced by a non- mouse-adapted EV71 strain in neonatal BALB/c mice , 2017, Virology Journal.

[27]  S. Black,et al.  ROS Signaling in the Pathogenesis of Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS) , 2017, Advances in experimental medicine and biology.

[28]  P. Zhang,et al.  Involvement of inducible nitric oxide synthase and mitochondrial dysfunction in the pathogenesis of enterovirus 71 infection , 2017, Oncotarget.

[29]  Hongjie Yu,et al.  Pulmonary and central nervous system pathology in fatal cases of hand foot and mouth disease caused by enterovirus A71 infection. , 2016, Pathology.

[30]  Li Feng,et al.  Neurological complications and risk factors of cardiopulmonary failure of EV-A71-related hand, foot and mouth disease , 2016, Scientific Reports.

[31]  M. Farrar,et al.  Clinical Characteristics and Functional Motor Outcomes of Enterovirus 71 Neurological Disease in Children. , 2016, JAMA neurology.

[32]  Xiuhui Li,et al.  Elevated levels of circulating histones indicate disease activity in patients with hand, foot, and mouth disease (HFMD) , 2014, Scandinavian journal of infectious diseases.

[33]  G. Duan,et al.  Serum Inflammatory Cytokine Levels Correlate with Hand-Foot-Mouth Disease Severity: A Nested Serial Case-Control Study , 2014, PloS one.

[34]  Li Zhang,et al.  Deferoxamine Compensates for Decreases in B Cell Counts and Reduces Mortality in Enterovirus 71-Infected Mice , 2014, Marine drugs.

[35]  Hong Yang,et al.  Emergence, Circulation, and Spatiotemporal Phylogenetic Analysis of Coxsackievirus A6- and Coxsackievirus A10-Associated Hand, Foot, and Mouth Disease Infections from 2008 to 2012 in Shenzhen, China , 2013, Journal of Clinical Microbiology.

[36]  Samson S. Y. Wong,et al.  Recombinant Coxsackievirus A2 and Deaths of Children, Hong Kong, 2012 , 2013, Emerging infectious diseases.

[37]  J. Koskenkari,et al.  Neurogenic Pulmonary Edema in Patients with Nontraumatic Intracerebral Hemorrhage: Predictors and Association with Outcome , 2013, Anesthesia and analgesia.

[38]  M. Menger,et al.  Distinct patterns of leukocyte recruitment in the pulmonary microvasculature in response to local and systemic inflammation. , 2013, American journal of physiology. Lung cellular and molecular physiology.

[39]  Kwok-Hung Chan,et al.  Recombinant Coxsackievirus A2 and Deaths of Children , 2013 .

[40]  H. Lei,et al.  Exogenous interleukin-6, interleukin-13, and interferon-gamma provoke pulmonary abnormality with mild edema in enterovirus 71-infected mice , 2011, Respiratory research.

[41]  K. Chua,et al.  The Distribution of Inflammation and Virus in Human Enterovirus 71 Encephalomyelitis Suggests Possible Viral Spread by Neural Pathways , 2008, Journal of neuropathology and experimental neurology.

[42]  Chin‐Yun Lee,et al.  Status of Cellular Rather Than Humoral Immunity is Correlated with Clinical Outcome of Enterovirus 71 , 2006, Pediatric Research.

[43]  Jen-Ren Wang,et al.  Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. , 2003, The Journal of infectious diseases.

[44]  U. Parashar,et al.  Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[45]  T. Tötterman,et al.  Phenotypic and functional activation of alveolar macrophages, T lymphocytes and NK cells in patients with systemic sclerosis and primary Sjögren's syndrome. , 1994, Annals of the rheumatic diseases.

[46]  L. Reed,et al.  A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .